Application: | Internal Medicine |
---|---|
Usage Mode: | Injection |
Suitable for: | Elderly, Children, Adult |
State: | Liquid |
Shape: | Injection |
Type: | Organic Chemicals |
Samples: |
---|
Customization: |
---|
Suppliers with verified business licenses
Lincomycin Hydrochloride Injection contains lincomycin hydrochloride in a sterile, clear, colorless solution with benzyl alcohol used as a preservative 9.45 mg/mL, and water for injection.
Lincomycin Hydrochloride Injection is a sterile solution for intramuscular and intravenous use, is supplied in 2 mL and 10 mL multiple-dose vials containing the equivalent of 300 mg/mL of lincomycin as lincomycin hydrochloride salt.
Lincomycin Sterile Solution is indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of CDAD, as described in the BOXED WARNING, before selecting lincomycin the physician should consider the nature of the infection and the suitability of other alternatives.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Lincomycin and other antibacterial drugs, Lincomycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Suppliers with verified business licenses